TY - JOUR
T1 - T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells
AU - Lepore, Marco
AU - Lewinsohn, Deborah A.
AU - Lewinsohn, David M.
N1 - Funding Information:
This work was supported by the National Institutes of Health R01 AI129980, R01 AI134790, and R01AI147954 and United States Department of Veterans Affairs BX000533.
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2021/2
Y1 - 2021/2
N2 - The monomorphic MHC-class I-like molecule, MR1, presents small metabolites to T cells. MR1 is the restriction element for microbe-reactive mucosal-associated invariant T (MAIT) cells. MAIT cells have limited TCR usage, including a semi-invariant TCR alpha chain and express high levels of CD161 and CD26. In addition to microbial lumazine metabolites, recent studies have demonstrated that MR1 is able to capture a variety of diverse chemical entities including folate-derivatives, a number of drug-like and other synthetic small molecules, and as yet undefined compounds of self-origin. This capacity of MR1 to bind distinct ligands likely accounts for the recent identification of additional, non-canonical, subsets of MR1-restricted T (MR1T) cells. These subsets can be defined based on their ability to recognize diverse microbes as well as their reactivity to non-microbial cell-endogenous ligands, including tumor-associated antigens. Herein, we will discuss our current understanding of MR1T cell diversity in terms of TCR usage, ligand recognition and functional attributes.
AB - The monomorphic MHC-class I-like molecule, MR1, presents small metabolites to T cells. MR1 is the restriction element for microbe-reactive mucosal-associated invariant T (MAIT) cells. MAIT cells have limited TCR usage, including a semi-invariant TCR alpha chain and express high levels of CD161 and CD26. In addition to microbial lumazine metabolites, recent studies have demonstrated that MR1 is able to capture a variety of diverse chemical entities including folate-derivatives, a number of drug-like and other synthetic small molecules, and as yet undefined compounds of self-origin. This capacity of MR1 to bind distinct ligands likely accounts for the recent identification of additional, non-canonical, subsets of MR1-restricted T (MR1T) cells. These subsets can be defined based on their ability to recognize diverse microbes as well as their reactivity to non-microbial cell-endogenous ligands, including tumor-associated antigens. Herein, we will discuss our current understanding of MR1T cell diversity in terms of TCR usage, ligand recognition and functional attributes.
KW - Heterogeneity
KW - MAIT
KW - MR1
KW - MR1-rescticted T cells
KW - TCR
UR - http://www.scopus.com/inward/record.url?scp=85098089931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098089931&partnerID=8YFLogxK
U2 - 10.1016/j.molimm.2020.12.009
DO - 10.1016/j.molimm.2020.12.009
M3 - Article
C2 - 33360378
AN - SCOPUS:85098089931
SN - 0161-5890
VL - 130
SP - 64
EP - 68
JO - Molecular Immunology
JF - Molecular Immunology
ER -